207 related articles for article (PubMed ID: 12612967)
1. Carnitine and hemodialysis.
Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
[TBL] [Abstract][Full Text] [Related]
2. Advances in carnitine in chronic uremia.
Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
[TBL] [Abstract][Full Text] [Related]
3. Carnitine metabolism in uremia.
Guarnieri G; Situlin R; Biolo G
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S63-7. PubMed ID: 11576925
[TBL] [Abstract][Full Text] [Related]
4. Carnitine replacement in end-stage renal disease and hemodialysis.
Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
[TBL] [Abstract][Full Text] [Related]
5. History of L-carnitine: implications for renal disease.
Matera M; Bellinghieri G; Costantino G; Santoro D; Calvani M; Savica V
J Ren Nutr; 2003 Jan; 13(1):2-14. PubMed ID: 12563618
[TBL] [Abstract][Full Text] [Related]
6. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Reuter SE; Faull RJ; Evans AM
Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
[TBL] [Abstract][Full Text] [Related]
8. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
[TBL] [Abstract][Full Text] [Related]
9. L-carnitine in dialysis patients.
Ahmad S
Semin Dial; 2001; 14(3):209-17. PubMed ID: 11422928
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Carnitine in maintenance hemodialysis patients.
Guarnieri G
J Ren Nutr; 2015 Mar; 25(2):169-75. PubMed ID: 25600394
[TBL] [Abstract][Full Text] [Related]
12. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
Schreiber BD
Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
[TBL] [Abstract][Full Text] [Related]
13. L carnitine in hemodialysis patients.
Calò LA; Vertolli U; Davis PA; Savica V
Hemodial Int; 2012 Jul; 16(3):428-34. PubMed ID: 22360675
[TBL] [Abstract][Full Text] [Related]
14. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation.
Murphy WJ; Steiber A; Connery GC; Carder J; Spry L; Hoppel C
Nephrol Dial Transplant; 2012 Jan; 27(1):304-10. PubMed ID: 21765185
[TBL] [Abstract][Full Text] [Related]
15. Carnitine nutriture of dialysis patients.
Borum PR; Taggart EM
J Am Diet Assoc; 1986 May; 86(5):644-7. PubMed ID: 3700927
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
17. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients.
Bellinghieri G; Santoro D; Calvani M; Savica V
J Ren Nutr; 2005 Jan; 15(1):13-7. PubMed ID: 15648000
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
[TBL] [Abstract][Full Text] [Related]
19. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
Glöggler A; Bulla M; Fürst P
Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
[TBL] [Abstract][Full Text] [Related]
20. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]